Recruiting Kidney Cancer Studies in New Brunswick
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread ...
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
The purpose of this study is to determine if the use of immunotherapy nivolumab and the targeted therapy cabozantinib prior to removal of the kidney, will increase the number subjects who are without ...
About Kidney Cancer Clinical Trials in New Brunswick
Kidney cancer, most commonly renal cell carcinoma, develops in the lining of the kidney tubules. It accounts for about 3-5% of all adult cancers. Treatment includes surgery, targeted therapy, immunotherapy, and radiation.
There are currently 2 kidney cancer clinical trials recruiting participants in New Brunswick, NJ. These studies are seeking a combined 113 participants. Research is being sponsored by National Cancer Institute (NCI), Mark Stein. Clinical trial participation is free and participants receive study-related medical care at no cost.
Kidney Cancer Clinical Trials in New Brunswick — FAQ
Are there kidney cancer clinical trials in New Brunswick?
Yes, there are 2 kidney cancer clinical trials currently recruiting in New Brunswick, NJ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Brunswick?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Brunswick research site will contact you about next steps.
Are clinical trials in New Brunswick free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Brunswick studies also compensate for your time and travel.
What kidney cancer treatments are being tested?
The 2 active trials in New Brunswick are testing new therapies including novel drugs, biologics, and treatment approaches for kidney cancer.
Data updated March 2, 2026 from ClinicalTrials.gov